stroke
As part of the program, point-of-care tests sold by Genedrive and Genomadix will be assessed, as well as laboratory-developed tests used within the UK National Health Service.
The companies were recently awarded a €2.4 million Eurostars grant to support the development and validation of the assay.
The firm said a test it has developed on the back of a large clinical trial detected cardioembolic stroke with 90 percent sensitivity and 70 percent specificity.
Prevencio, Atlas Genomics to Commercialize Cardiac Blood Tests
The tests use Microsoft's Azure AI-based computing cloud platform for test algorithm processing and scoring and for report generation and delivery.
ABCDx Prepping for EU, US Regulatory Submissions of POC Stroke Test
The company is targeting a 2021 US launch for the test, which uses a pair of protein markers to diagnose stroke and allow treatment to begin more quickly.